Antibodies, Anti-Idiotypic
"Antibodies, Anti-Idiotypic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Antibodies which react with the individual structural determinants (idiotopes) on the variable region of other antibodies.
| Descriptor ID |
D000888
|
| MeSH Number(s) |
D12.776.124.486.485.114.071 D12.776.124.790.651.114.071 D12.776.377.715.548.114.071
|
| Concept/Terms |
Antibodies, Anti-Idiotypic- Antibodies, Anti-Idiotypic
- Anti-Idiotypic Antibodies
- Antibodies, Anti Idiotypic
- Anti-Idiotype Antibodies
- Anti Idiotype Antibodies
- Antibodies, Anti-Idiotype
Anti-Antibodies- Anti-Antibodies
- Antiglobulins
- Antigamma Globulin Antibodies
- Antibodies, Antigamma Globulin
- Globulin Antibodies, Antigamma
- Anti Antibodies
- Antibodies, Anti
- Anti-gamma Globulin Antibodies
- Anti gamma Globulin Antibodies
- Antibodies, Anti-gamma Globulin
- Globulin Antibodies, Anti-gamma
|
Below are MeSH descriptors whose meaning is more general than "Antibodies, Anti-Idiotypic".
Below are MeSH descriptors whose meaning is more specific than "Antibodies, Anti-Idiotypic".
This graph shows the total number of publications written about "Antibodies, Anti-Idiotypic" by people in this website by year, and whether "Antibodies, Anti-Idiotypic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 2 | 2 |
| 1998 | 0 | 1 | 1 |
| 1999 | 1 | 1 | 2 |
| 2000 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2005 | 0 | 2 | 2 |
| 2007 | 1 | 0 | 1 |
| 2008 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2011 | 2 | 1 | 3 |
| 2012 | 0 | 2 | 2 |
| 2013 | 2 | 0 | 2 |
| 2014 | 2 | 1 | 3 |
| 2015 | 0 | 1 | 1 |
| 2017 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antibodies, Anti-Idiotypic" by people in Profiles.
-
Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study. Breast Cancer Res Treat. 2018 02; 167(3):671-686.
-
Magnetic Resonance Elastography Shear Wave Velocity Correlates with Liver Fibrosis and Hepatic Venous Pressure Gradient in Adults with Advanced Liver Disease. Biomed Res Int. 2017; 2017:2067479.
-
Randomized, Double-Blind, Placebo-Controlled Trial of the Effect of Vitamin D3 on the Interferon Signature in Patients With Systemic Lupus Erythematosus. Arthritis Rheumatol. 2015 Jul; 67(7):1848-57.
-
Biologic agents and the therapy of chronic spontaneous urticaria. Curr Opin Allergy Clin Immunol. 2014 Aug; 14(4):347-53.
-
Therapy of chronic urticaria: a simple, modern approach. Ann Allergy Asthma Immunol. 2014 May; 112(5):419-25.
-
The maddening itch: an approach to chronic urticaria. J Investig Allergol Clin Immunol. 2014; 24(1):1-5.
-
Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy. J Allergy Clin Immunol. 2013 Jul; 132(1):101-9.
-
Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria. N Engl J Med. 2013 Mar 07; 368(10):924-35.
-
Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012 Aug; 64(8):2677-86.
-
Biologic agents in the treatment of urticaria. Curr Allergy Asthma Rep. 2012 Aug; 12(4):288-91.